Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.77
+0.03 (0.18%)
Oct 15, 2026, 11:31 AM EDT - Market open
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.61 billion as of October 15, 2026. It is the 4,551st most valuable company in the world and the 1,362nd biggest in the United States. Its market cap has increased by 45.45% in one year.
Market Cap
3.61B
Enterprise Value
11.04B
1-Year Change
45.45%
Global Rank
Country Rank
#1,362 United States
Category
ChartMarket Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.61B, a decrease of -57.05%. That is a compound annual growth rate of -14.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 3.61B | 93.92% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 245.36B |
| Amgen | 224.63B |
| Gilead Sciences | 186.25B |
| Novo Nordisk | 168.37B |
| Pfizer | 161.79B |
| Bristol-Myers Squibb Company | 116.41B |
| Sanofi | 95.46B |
| GSK plc | 93.93B |